Amgen (AMGN) Other Working Capital Changes (2009 - 2026)

Amgen's Other Working Capital Changes history runs 18 years deep, the most recent figure standing at -$8.0 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 103.98% year-over-year to -$8.0 million; the TTM figure through Mar 2026 stood at $1.1 billion (up 38.48% YoY), while the FY2025 annual figure was $1.3 billion, up 94.33% from the prior year.
• Other Working Capital Changes was -$8.0 million for Q1 2026 at Amgen, down from $577.0 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $577.0 million in Q4 2025 to a low of -$241.0 million in Q2 2022.
• Historically, Other Working Capital Changes has averaged $130.4 million across 5 years, with a median of $139.0 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes slumped 315.18% in 2022, then soared 4021.43% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at -$92.0 million in 2022, then jumped by 352.17% to $232.0 million in 2023, then sank by 93.97% to $14.0 million in 2024, then jumped by 4021.43% to $577.0 million in 2025, then slumped by 101.39% to -$8.0 million in 2026.
• The last three Other Working Capital Changes figures came in at -$8.0 million (Q1 2026), $577.0 million (Q4 2025), and $283.0 million (Q3 2025), per Business Quant data.